Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

aTyr Pharma, Inc. Common Stock

ATYR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ATYR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ATYR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ATYR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ATYR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ATYR holdings by institutional investors

Quarterly net insider trading by ATYR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ATYR

Quiver Logo

No former government officials on record as having lobbied for ATYR

Revolving Door Dashboard

ATYR Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ATYR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ATYR Income Statement
ATYR Balance Sheet
ATYR Cash Flow
U.S. Patents

New ATYR patent grants

  • Patent Title: Aminoacyl trna synthetases for modulating inflammation Apr. 17, 2018
  • Patent Title: Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities Feb. 20, 2018
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases Feb. 20, 2018
  • Patent Title: Pegylated aspartyl-trna synthetase polypeptides Nov. 21, 2017
  • Patent Title: Aspartyl-trna synthetases Nov. 14, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases Oct. 24, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases Oct. 17, 2017
  • Patent Title: Pegylated tyrosyl-trna synthetase polypeptides Jul. 25, 2017
  • Patent Title: Aspartyl-trna synthetase-fc conjugates Jun. 27, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases Jun. 27, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases May. 02, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases Apr. 18, 2017
  • Patent Title: Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities Mar. 28, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases Mar. 14, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases Mar. 14, 2017
  • Patent Title: Histidyl-trna synthetase-fc conjugates Mar. 07, 2017
  • Patent Title: Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activities Mar. 07, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-trna synthetases Feb. 28, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases Feb. 21, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl-trna synthetases Jan. 31, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase Jan. 10, 2017
  • Patent Title: Aminoacyl trna synthetases for modulating inflammation Jan. 10, 2017
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases Dec. 27, 2016
  • Patent Title: Thrombopoietic activity of tyrosyl-trna synthetase polypeptides Nov. 22, 2016
  • Patent Title: Polypeptide structural motifs associated with cell signaling activity Sep. 27, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases Aug. 30, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases Aug. 23, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetasis Aug. 23, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex Aug. 02, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl-trna synthetases Jul. 26, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases May. 24, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases May. 17, 2016
  • Patent Title: Amino acyl trna synthetases for modulating inflammation May. 03, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases Apr. 26, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases Apr. 26, 2016
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases Apr. 19, 2016
  • Patent Title: Histidyl-trna synthetases for treating autoimmune and inflammatory diseases Mar. 01, 2016
  • Patent Title: Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activities Oct. 13, 2015
  • Patent Title: Aminoacyl trna synthetases for modulating inflammation Sep. 08, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases Jun. 30, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex Jun. 23, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases Jun. 23, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases May. 19, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases May. 19, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl-trna synthetases May. 19, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases May. 12, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases Apr. 07, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-trna synthetases Mar. 31, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-trna synthetases Mar. 24, 2015
  • Patent Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases Mar. 24, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ATYR from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ATYR News

Recent insights relating to ATYR

CNBC Recommendations

Recent picks made for ATYR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ATYR

ATYR Analyst Ratings

ATYR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ATYR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ATYR stock a Buy, Sell, or Hold?

  • What is the price target for $ATYR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ATYR Top Shareholders
Shareholder
Shares Held
ATYR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ATYR stock?

  • Who owns the most shares of $ATYR stock?

  • What funds own $ATYR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ATYR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ATYR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ATYR

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

  • Address San Diego, CA
  • Market Cap 35.0 million
  • Employees 58
  • Industrial Classification Biological Products, (No Diagnostic Substances)

aTyr Pharma, Inc. Common Stock (ATYR) Historical Stock Prices

aTyr Pharma, Inc. Common Stock (ATYR) closed at $0.3564 on September 22, 2026. Over the past year its adjusted close ranged from $0.3564 to $1.06. Daily prices go back to January 2, 2014, 2,883 trading days in all.

  • 1 month-28.93%
  • 3 months-33.64%
  • Year to date-54.49%
  • 1 year-66.06%
  • 3 years-77.86%
  • 5 years-97.14%
  • Max-99.53%
See every congressional and insider trade on the ATYR price chart

Quiver Premium charts ATYR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 0.3816 0.3816 0.3510 0.3564 0.3564 1,335,764
Sep 21, 2026 0.3800 0.3800 0.3685 0.3728 0.3728 918,661
Sep 18, 2026 0.3700 0.3880 0.3600 0.3630 0.3630 1,268,548
Sep 17, 2026 0.3950 0.3981 0.3700 0.3765 0.3765 1,004,490
Sep 16, 2026 0.3958 0.3958 0.3787 0.3841 0.3841 954,173
Sep 15, 2026 0.3940 0.4008 0.3750 0.3892 0.3892 1,059,982
Sep 14, 2026 0.4200 0.4341 0.3820 0.3886 0.3886 1,731,686
Sep 11, 2026 0.4356 0.4464 0.4217 0.4298 0.4298 1,425,365
Sep 10, 2026 0.4690 0.4694 0.4301 0.4319 0.4319 923,533
Sep 9, 2026 0.4800 0.4860 0.4505 0.4554 0.4554 829,820
Sep 8, 2026 0.5100 0.5100 0.4800 0.4808 0.4808 634,189
Sep 4, 2026 0.4900 0.5080 0.4872 0.4973 0.4973 253,799
Sep 3, 2026 0.5050 0.5091 0.4800 0.5035 0.5035 385,333
Sep 2, 2026 0.4821 0.5091 0.4820 0.4930 0.4930 700,088
Sep 1, 2026 0.5300 0.5336 0.4750 0.4765 0.4765 1,173,067
Aug 31, 2026 0.5400 0.5431 0.5011 0.5317 0.5317 1,023,603
Aug 28, 2026 0.5600 0.5650 0.5300 0.5400 0.5400 266,253
Aug 27, 2026 0.5620 0.5620 0.5445 0.5546 0.5546 294,279
Aug 26, 2026 0.5725 0.5725 0.5310 0.5510 0.5510 304,793
Aug 25, 2026 0.5386 0.5700 0.5322 0.5700 0.5700 677,070
Aug 24, 2026 0.5106 0.5340 0.4900 0.5300 0.5300 690,247
Aug 21, 2026 0.5099 0.5340 0.5002 0.5015 0.5015 522,705
Aug 20, 2026 0.5168 0.5240 0.5000 0.5030 0.5030 766,768
Aug 19, 2026 0.5115 0.5375 0.5027 0.5328 0.5328 600,459
Aug 18, 2026 0.5298 0.5450 0.5027 0.5041 0.5041 679,194
Aug 17, 2026 0.5410 0.5699 0.5180 0.5189 0.5189 625,873
Aug 14, 2026 0.5600 0.5867 0.5500 0.5590 0.5590 656,618
Aug 13, 2026 0.5500 0.6000 0.5436 0.5530 0.5530 1,270,224
Aug 12, 2026 0.5440 0.5570 0.5253 0.5403 0.5403 331,527
Aug 11, 2026 0.5400 0.5421 0.5141 0.5340 0.5340 495,316
Aug 10, 2026 0.5345 0.5381 0.5056 0.5289 0.5289 610,906
Aug 7, 2026 0.4964 0.5200 0.4964 0.5114 0.5114 369,834
Aug 6, 2026 0.5290 0.5290 0.4900 0.5020 0.5020 582,645
Aug 5, 2026 0.5292 0.5300 0.5031 0.5290 0.5290 458,007
Aug 4, 2026 0.5100 0.5350 0.5055 0.5292 0.5292 974,958
Aug 3, 2026 0.4928 0.5100 0.4801 0.4920 0.4920 774,600
Jul 31, 2026 0.4950 0.5000 0.4748 0.4857 0.4857 396,651
Jul 30, 2026 0.4800 0.4925 0.4760 0.4800 0.4800 627,373
Jul 29, 2026 0.4844 0.5000 0.4752 0.4830 0.4830 599,027
Jul 28, 2026 0.4855 0.5027 0.4700 0.4940 0.4940 932,178
Jul 27, 2026 0.4800 0.4973 0.4748 0.4896 0.4896 683,757
Jul 24, 2026 0.5000 0.5090 0.4733 0.4733 0.4733 825,955
Jul 23, 2026 0.4785 0.5100 0.4555 0.4981 0.4981 1,375,045
Jul 22, 2026 0.4800 0.5059 0.4800 0.4870 0.4870 897,417
Jul 21, 2026 0.4900 0.5073 0.4800 0.4859 0.4859 864,674
Jul 20, 2026 0.5036 0.5250 0.4864 0.4864 0.4864 811,078
Jul 17, 2026 0.5100 0.5199 0.4830 0.5098 0.5098 713,495
Jul 16, 2026 0.5337 0.5415 0.4966 0.5159 0.5159 1,371,419
Jul 15, 2026 0.5235 0.5610 0.5000 0.5343 0.5343 6,280,832
Jul 14, 2026 0.5200 0.5211 0.4700 0.4860 0.4860 938,178
Jul 13, 2026 0.5310 0.5669 0.5007 0.5041 0.5041 797,821
Jul 10, 2026 0.5801 0.5899 0.5350 0.5444 0.5444 1,404,901
Jul 9, 2026 0.6400 0.6461 0.5770 0.5817 0.5817 1,466,972
Jul 8, 2026 0.5884 0.6798 0.5884 0.6431 0.6431 2,381,098
Jul 7, 2026 0.6500 0.6998 0.6000 0.6061 0.6061 2,355,212
Jul 6, 2026 0.6000 0.6567 0.6000 0.6539 0.6539 1,665,012
Jul 2, 2026 0.5898 0.6062 0.5733 0.5925 0.5925 1,476,533
Jul 1, 2026 0.5968 0.6243 0.5709 0.5898 0.5898 1,442,000
Jun 30, 2026 0.5600 0.6100 0.5501 0.5968 0.5968 1,355,671
Jun 29, 2026 0.5399 0.5704 0.5277 0.5664 0.5664 1,441,183
Jun 26, 2026 0.5500 0.5814 0.5200 0.5275 0.5275 12,153,229
Jun 25, 2026 0.5800 0.5900 0.5425 0.5597 0.5597 1,788,999
Jun 24, 2026 0.5200 0.5948 0.5105 0.5615 0.5615 3,640,704
Jun 23, 2026 0.4634 0.5599 0.4634 0.5371 0.5371 2,898,065
Jun 22, 2026 0.4536 0.4876 0.4530 0.4702 0.4702 1,875,492
Jun 18, 2026 0.4762 0.4883 0.4501 0.4505 0.4505 1,533,392
Jun 17, 2026 0.4423 0.4972 0.4423 0.4629 0.4629 1,582,927
Jun 16, 2026 0.4426 0.4600 0.4408 0.4478 0.4478 643,231
Jun 15, 2026 0.4688 0.4758 0.4420 0.4433 0.4433 1,620,887
Jun 12, 2026 0.4726 0.4750 0.4400 0.4404 0.4404 1,428,264
Jun 11, 2026 0.4690 0.4800 0.4400 0.4754 0.4754 1,230,505
Jun 10, 2026 0.4622 0.4805 0.4482 0.4684 0.4684 969,333
Jun 9, 2026 0.4550 0.4744 0.4360 0.4556 0.4556 1,776,974
Jun 8, 2026 0.4730 0.4742 0.4401 0.4421 0.4421 1,778,427
Jun 5, 2026 0.5214 0.5214 0.4559 0.4700 0.4700 2,784,597
Jun 4, 2026 0.5070 0.5401 0.5070 0.5130 0.5130 1,472,727
Jun 3, 2026 0.5069 0.5291 0.5000 0.5001 0.5001 1,730,342
Jun 2, 2026 0.5600 0.5600 0.5171 0.5200 0.5200 1,936,735
Jun 1, 2026 0.5311 0.5909 0.5102 0.5466 0.5466 4,420,333
May 29, 2026 0.5354 0.5659 0.5200 0.5425 0.5425 5,434,479
May 28, 2026 0.4800 0.5000 0.4640 0.4874 0.4874 9,861,796
May 27, 2026 0.4959 0.5000 0.4730 0.4782 0.4782 2,516,947
May 26, 2026 0.4900 0.5031 0.4785 0.4843 0.4843 2,282,446
May 22, 2026 0.5285 0.5360 0.4900 0.4900 0.4900 3,186,024
May 21, 2026 0.5200 0.5526 0.5112 0.5285 0.5285 2,765,166
May 20, 2026 0.5000 0.5460 0.4951 0.5306 0.5306 3,412,927
May 19, 2026 0.5010 0.5265 0.4815 0.4830 0.4830 2,876,861
May 18, 2026 0.5061 0.5375 0.4603 0.5195 0.5195 5,394,201
May 15, 2026 0.5800 0.5800 0.4928 0.5040 0.5040 3,538,060
May 14, 2026 0.4169 0.5788 0.4150 0.5599 0.5599 13,901,993
May 13, 2026 0.5430 0.5430 0.3950 0.3959 0.3959 13,336,688
May 12, 2026 0.8000 0.8034 0.5100 0.5302 0.5302 12,306,880
May 11, 2026 0.9524 0.9925 0.9323 0.9502 0.9502 1,116,575
May 8, 2026 0.9400 0.9600 0.9014 0.9463 0.9463 905,145
May 7, 2026 1.03 1.03 0.9000 0.9218 0.9218 1,257,208
May 6, 2026 0.8466 1.05 0.8300 1.04 1.04 4,184,093
May 5, 2026 0.8569 0.8590 0.8200 0.8422 0.8422 750,199
May 4, 2026 0.8528 0.8601 0.8234 0.8429 0.8429 757,206
May 1, 2026 0.8138 0.8750 0.8110 0.8335 0.8335 1,569,052
Apr 30, 2026 0.7600 0.8129 0.7600 0.8074 0.8074 752,286
Apr 29, 2026 0.8000 0.8016 0.7522 0.7650 0.7650 1,004,959
Apr 28, 2026 0.7870 0.8130 0.7800 0.7936 0.7936 585,675
Apr 27, 2026 0.7900 0.8355 0.7722 0.7909 0.7909 1,155,386
Apr 24, 2026 0.7833 0.8159 0.7799 0.7851 0.7851 910,152
Apr 23, 2026 0.8467 0.8467 0.7850 0.7917 0.7917 836,666
Apr 22, 2026 0.8349 0.8649 0.8300 0.8443 0.8443 751,307
Apr 21, 2026 0.8410 0.8579 0.8178 0.8235 0.8235 584,458
Apr 20, 2026 0.8558 0.8699 0.8415 0.8532 0.8532 850,371
Apr 17, 2026 0.8500 0.8700 0.8320 0.8534 0.8534 700,920
Apr 16, 2026 0.8590 0.8699 0.8250 0.8305 0.8305 613,391
Apr 15, 2026 0.8500 0.8724 0.8301 0.8427 0.8427 1,058,544
Apr 14, 2026 0.8200 0.8750 0.8200 0.8409 0.8409 654,029
Apr 13, 2026 0.8300 0.8500 0.8000 0.8104 0.8104 793,198
Apr 10, 2026 0.7700 0.8480 0.7516 0.8324 0.8324 980,599
Apr 9, 2026 0.7860 0.8000 0.7500 0.7500 0.7500 1,198,159
Apr 8, 2026 0.8301 0.8351 0.7923 0.7998 0.7998 686,108
Apr 7, 2026 0.8086 0.8200 0.7626 0.7951 0.7951 919,553
Apr 6, 2026 0.8400 0.8664 0.8201 0.8240 0.8240 729,175
Apr 2, 2026 0.8393 0.8700 0.8120 0.8469 0.8469 704,056
Apr 1, 2026 0.8000 0.8649 0.7900 0.8508 0.8508 1,801,784
Mar 31, 2026 0.7390 0.7800 0.7390 0.7800 0.7800 1,034,827
Mar 30, 2026 0.7500 0.7554 0.7200 0.7309 0.7309 1,476,490
Mar 27, 2026 0.7758 0.7927 0.7500 0.7520 0.7520 1,300,649
Mar 26, 2026 0.7800 0.8112 0.7800 0.7927 0.7927 789,571
Mar 25, 2026 0.7957 0.8395 0.7708 0.7993 0.7993 1,475,526
Mar 24, 2026 0.8201 0.8245 0.7800 0.7896 0.7896 767,871
Mar 23, 2026 0.8270 0.8458 0.8003 0.8274 0.8274 896,808
Mar 20, 2026 0.8247 0.8455 0.8006 0.8083 0.8083 876,618
Mar 19, 2026 0.8165 0.8449 0.7900 0.8276 0.8276 1,055,414
Mar 18, 2026 0.8800 0.8935 0.8142 0.8150 0.8150 801,340
Mar 17, 2026 0.9000 0.9098 0.8702 0.8815 0.8815 652,723
Mar 16, 2026 0.8500 0.8999 0.8410 0.8945 0.8945 963,611
Mar 13, 2026 0.8800 0.8990 0.8252 0.8500 0.8500 791,090
Mar 12, 2026 0.9000 0.9100 0.8500 0.8675 0.8675 1,173,654
Mar 11, 2026 0.9169 0.9350 0.9000 0.9219 0.9219 565,148
Mar 10, 2026 0.9040 0.9700 0.9000 0.9358 0.9358 1,124,918
Mar 9, 2026 0.8200 0.9040 0.8200 0.8996 0.8996 1,556,271
Mar 6, 2026 0.8746 0.8880 0.8200 0.8240 0.8240 1,754,762
Mar 5, 2026 0.9451 0.9644 0.8900 0.9023 0.9023 1,302,605
Mar 4, 2026 0.9600 0.9963 0.9201 0.9645 0.9645 1,040,652
Mar 3, 2026 0.9500 0.9704 0.8547 0.9599 0.9599 1,249,668
Mar 2, 2026 0.9300 0.9900 0.9251 0.9900 0.9900 1,280,214
Feb 27, 2026 0.9900 1.01 0.9406 0.9598 0.9598 933,497
Feb 26, 2026 1.03 1.03 0.9651 0.9900 0.9900 1,408,507
Feb 25, 2026 0.9800 1.04 0.9800 1.02 1.02 1,208,378
Feb 24, 2026 0.9983 1.03 0.9600 0.9888 0.9888 1,333,950
Feb 23, 2026 1.05 1.10 0.9901 1.01 1.01 2,260,049
Feb 20, 2026 1.05 1.07 0.9975 1.04 1.04 1,527,520
Feb 19, 2026 0.9700 1.11 0.9641 1.05 1.05 3,005,464
Feb 18, 2026 0.9713 1.02 0.9600 0.9942 0.9942 1,970,197
Feb 17, 2026 0.8850 1.00 0.8744 0.9830 0.9830 2,611,526
Feb 13, 2026 0.8900 0.9473 0.8703 0.8939 0.8939 1,369,199
Feb 12, 2026 0.9100 0.9181 0.8523 0.8909 0.8909 1,169,194
Feb 11, 2026 0.8881 0.9268 0.8200 0.9268 0.9268 1,968,679
Feb 10, 2026 0.8837 0.9352 0.8652 0.8800 0.8800 1,316,489
Feb 9, 2026 0.9235 0.9240 0.8362 0.8995 0.8995 1,351,401
Feb 6, 2026 0.8289 0.9220 0.8163 0.8990 0.8990 1,629,523
Feb 5, 2026 0.8600 0.9000 0.8102 0.8107 0.8107 2,016,733
Feb 4, 2026 0.9610 1.03 0.8700 0.8805 0.8805 2,026,487
Feb 3, 2026 0.9743 1.04 0.8700 0.9602 0.9602 3,573,105
Feb 2, 2026 0.8800 1.02 0.8701 0.9702 0.9702 7,287,670
Jan 30, 2026 0.8450 0.8869 0.8204 0.8828 0.8828 3,124,869
Jan 29, 2026 0.7500 0.8950 0.7400 0.8506 0.8506 15,728,811
Jan 28, 2026 0.7010 0.7101 0.6701 0.6742 0.6742 886,494
Jan 27, 2026 0.7018 0.7200 0.6900 0.7070 0.7070 859,989
Jan 26, 2026 0.7101 0.7337 0.7003 0.7007 0.7007 1,160,602
Jan 23, 2026 0.7300 0.7443 0.7148 0.7231 0.7231 740,320
Jan 22, 2026 0.7099 0.7590 0.7008 0.7464 0.7464 1,179,622
Jan 21, 2026 0.7016 0.7193 0.6910 0.7094 0.7094 828,768
Jan 20, 2026 0.6900 0.7299 0.6896 0.7065 0.7065 858,745
Jan 16, 2026 0.6972 0.7390 0.6966 0.7086 0.7086 1,252,321
Jan 15, 2026 0.7000 0.7434 0.6940 0.7065 0.7065 827,596
Jan 14, 2026 0.7000 0.7273 0.6907 0.7179 0.7179 1,033,177
Jan 13, 2026 0.6800 0.7099 0.6632 0.7061 0.7061 1,472,345
Jan 12, 2026 0.7092 0.7195 0.6562 0.6830 0.6830 2,437,339
Jan 9, 2026 0.7212 0.7400 0.7100 0.7127 0.7127 1,857,077
Jan 8, 2026 0.7300 0.7451 0.7170 0.7251 0.7251 1,349,232
Jan 7, 2026 0.7224 0.7620 0.7224 0.7465 0.7465 1,255,657
Jan 6, 2026 0.7341 0.7600 0.7106 0.7243 0.7243 2,249,052
Jan 5, 2026 0.7500 0.7784 0.7413 0.7460 0.7460 1,545,731
Jan 2, 2026 0.7831 0.8000 0.7401 0.7591 0.7591 1,157,653
Dec 31, 2025 0.7225 0.8503 0.7200 0.7831 0.7831 3,675,201
Dec 30, 2025 0.7200 0.7450 0.7150 0.7450 0.7450 1,471,480
Dec 29, 2025 0.7200 0.7486 0.7100 0.7486 0.7486 2,577,179
Dec 26, 2025 0.7270 0.7450 0.7048 0.7428 0.7428 1,712,790
Dec 24, 2025 0.7100 0.7399 0.7100 0.7381 0.7381 626,465
Dec 23, 2025 0.7145 0.7630 0.7100 0.7200 0.7200 2,073,627
Dec 22, 2025 0.7182 0.7475 0.7052 0.7259 0.7259 1,667,743
Dec 19, 2025 0.7000 0.7500 0.6906 0.7500 0.7500 5,868,341
Dec 18, 2025 0.7096 0.7480 0.7000 0.7031 0.7031 1,673,139
Dec 17, 2025 0.7326 0.7512 0.7029 0.7096 0.7096 1,260,086
Dec 16, 2025 0.7161 0.7543 0.7159 0.7326 0.7326 2,355,312
Dec 15, 2025 0.7628 0.7876 0.7260 0.7334 0.7334 1,730,821
Dec 12, 2025 0.7579 0.7950 0.7579 0.7755 0.7755 1,558,483
Dec 11, 2025 0.8100 0.8236 0.7611 0.7653 0.7653 1,588,300
Dec 10, 2025 0.8099 0.8300 0.7819 0.8160 0.8160 2,674,716
Dec 9, 2025 0.8001 0.8288 0.8000 0.8083 0.8083 1,081,374
Dec 8, 2025 0.8000 0.8354 0.8000 0.8122 0.8122 1,435,154
Dec 5, 2025 0.8293 0.8499 0.8100 0.8239 0.8239 1,484,078
Dec 4, 2025 0.7699 0.8596 0.7524 0.8278 0.8278 3,228,264
Dec 3, 2025 0.7050 0.7749 0.7001 0.7708 0.7708 2,324,088
Dec 2, 2025 0.7400 0.7467 0.7054 0.7054 0.7054 2,213,203
Dec 1, 2025 0.7700 0.8080 0.7411 0.7411 0.7411 2,464,317
Nov 28, 2025 0.7708 0.7967 0.7578 0.7805 0.7805 977,580
Nov 26, 2025 0.7742 0.7978 0.7412 0.7652 0.7652 1,777,176
Nov 25, 2025 0.7600 0.7892 0.7403 0.7674 0.7674 2,100,869
Nov 24, 2025 0.6600 0.7789 0.6542 0.7776 0.7776 4,015,109
Nov 21, 2025 0.6428 0.6898 0.6400 0.6645 0.6645 2,839,909
Nov 20, 2025 0.6900 0.7200 0.6514 0.6514 0.6514 4,354,486
Nov 19, 2025 0.7002 0.7199 0.6657 0.6752 0.6752 4,583,935
Nov 18, 2025 0.6826 0.7190 0.6808 0.7010 0.7010 4,273,700
Nov 17, 2025 0.7430 0.7699 0.6760 0.6802 0.6802 4,286,345
Nov 14, 2025 0.6910 0.7532 0.6880 0.7532 0.7532 3,498,861
Nov 13, 2025 0.7289 0.7440 0.6995 0.7134 0.7134 5,875,874
Nov 12, 2025 0.7696 0.8100 0.7228 0.7228 0.7228 5,416,039
Nov 11, 2025 0.7835 0.7996 0.7702 0.7873 0.7873 2,799,779
Nov 10, 2025 0.8100 0.8350 0.7720 0.7900 0.7900 3,861,578
Nov 7, 2025 0.7500 0.8300 0.7427 0.8169 0.8169 4,505,157
Nov 6, 2025 0.8100 0.8250 0.7703 0.7703 0.7703 3,460,802
Nov 5, 2025 0.8063 0.8300 0.7900 0.8138 0.8138 3,688,521
Nov 4, 2025 0.8400 0.8696 0.8175 0.8266 0.8266 2,682,714
Nov 3, 2025 0.8757 0.8815 0.8226 0.8807 0.8807 3,846,144
Oct 31, 2025 0.8896 0.9239 0.8660 0.8660 0.8660 3,637,336
Oct 30, 2025 0.9549 0.9602 0.8880 0.8880 0.8880 4,298,931
Oct 29, 2025 0.9600 0.9995 0.9506 0.9688 0.9688 4,081,391
Oct 28, 2025 0.9850 1.02 0.9600 0.9600 0.9600 3,606,306
Oct 27, 2025 0.9700 1.01 0.9693 0.9732 0.9732 3,410,955
Oct 24, 2025 0.9879 0.9900 0.9441 0.9656 0.9656 2,788,221
Oct 23, 2025 0.9648 0.9870 0.9412 0.9728 0.9728 2,753,458
Oct 22, 2025 1.02 1.05 0.9531 0.9663 0.9663 7,983,475
Oct 21, 2025 1.01 1.06 0.9952 1.03 1.03 7,040,763
Oct 20, 2025 1.03 1.04 0.9800 1.02 1.02 6,405,299
Oct 17, 2025 0.9900 1.04 0.9600 1.02 1.02 6,396,147
Oct 16, 2025 0.9950 1.10 0.9950 1.00 1.00 9,344,274
Oct 15, 2025 1.04 1.08 1.00 1.02 1.02 5,496,346
Oct 14, 2025 0.9244 1.06 0.9000 1.04 1.04 8,286,686
Oct 13, 2025 1.06 1.08 0.9500 0.9658 0.9658 9,581,435
Oct 10, 2025 1.07 1.12 1.01 1.06 1.06 21,621,367
Oct 9, 2025 0.9900 1.02 0.9266 0.9530 0.9530 10,278,798
Oct 8, 2025 0.8367 1.00 0.8101 1.00 1.00 11,937,731
Oct 7, 2025 0.8200 0.8469 0.7995 0.8363 0.8363 5,655,881
Oct 6, 2025 0.8000 0.8600 0.7901 0.8246 0.8246 10,686,853
Oct 3, 2025 0.7080 0.7899 0.7080 0.7752 0.7752 10,694,119
Oct 2, 2025 0.6967 0.7288 0.6900 0.7099 0.7099 10,576,465
Oct 1, 2025 0.7100 0.7400 0.6816 0.6904 0.6904 13,556,816
Sep 30, 2025 0.8247 0.8330 0.7000 0.7214 0.7214 23,582,075
Sep 29, 2025 0.8214 0.8373 0.7700 0.7952 0.7952 13,788,690
Sep 26, 2025 0.8722 0.9000 0.8020 0.8405 0.8405 16,689,673
Sep 25, 2025 0.9340 0.9600 0.8700 0.8933 0.8933 14,146,251
Sep 24, 2025 0.9887 0.9950 0.9510 0.9510 0.9510 12,251,525
Sep 23, 2025 1.04 1.05 0.9800 0.9901 0.9901 9,457,165
Sep 22, 2025 0.9600 1.05 0.9594 1.05 1.05 21,352,835

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
aTyr Pharma, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ATYR, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation